Development

Lilly reports a multibillion-dollar Houston plant

development2026-09-22biotech

Claim

The issue reports a $6.5 billion Houston plant associated with Lilly's manufacturing expansion.

Reported metric: $6.5B

Reporting date: (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Indexed from the September 22 newsletter. Linked-source claims have not been independently verified.

Knowledge graphopen in browser →

About
Reported in
Actor
Referenced by

Cite or correct this record

Suggest a correction — opens a GitHub draft for you to review and submit.